
October Letter From the President
By the time this newsletter goes out, October will be almost over. As with everything, there are positives (the Stage IV Stampede & Summit; the
Explore updates on metastatic breast cancer research, hear from the MBC community, and learn how your support is making a difference.

By the time this newsletter goes out, October will be almost over. As with everything, there are positives (the Stage IV Stampede & Summit; the

On October 5-6 METAvivor held its annual Stage IV Stampede & Summit and Hill Day in Washington D.C. For the first time, the in-person event

More than 325 landmarks worldwide will illuminate October 13; watch #LightUpMBC Live at 8 p.m. ET / 5 p.m. PT NEW YORK, NY, October 8,

Tameron Harvell is a nurse practitioner based in Huntsville, Alabama, with more than 20 years of experience in oncology and breast health. Her career has
Advocacy letters are one way METAvivor works to ensure the needs of people living with metastatic breast cancer are represented in policy decisions that affect

Lori Swain, MS, serves as Executive Director of the National Cancer Registrars Association (NCRA), a position she has held since 2001. During her more than

Taylarr Lopez is a dedicated public health communications leader with more than a decade of experience in health education, patient advocacy, and public health communication.

Meet Roxana Guerra, Bilingual Patient Advocate who has been living with metastatic breast cancer for nearly 10 years. Roxana was initially diagnosed with stage IIIC

METAvivor has transitioned from GoFundMe Pro (formerly Classy) to Bloomerang Fundraising for our Peer-to-Peer fundraising efforts. As of this fall, fundraising pages on GoFundMe Pro

Letter from the President Kelly Shanahan, M.D. Time really does move faster as we get older – or have a MBC diagnosis. It’s crazy to

As summer winds down, METAvivor’s Stage IV Stampede and Summit is approaching quickly, and we hope you’ll join us in Washington, DC. If you haven’t

METAvivor Signs On to Remove Financial Barriers to Clinical Trials METAvivor has joined 128 other patient advocacy groups, public health organizations, and professional societies in